Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Intervalo de año de publicación
1.
J Neuropsychiatry Clin Neurosci ; 32(2): 154-160, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31530118

RESUMEN

OBJECTIVE: The authors examined and compared the clinical presentation of CSF positive and negative N-methyl-d-aspartate receptor (NMDAR) antibody. METHODS: The investigators performed a retrospective chart review of NMDAR-antibody-positive cases (serum or CSF) involving patients presenting to psychiatric services from 2010 to 2018 in Queensland, Australia. Presentation, progress, investigations, and efficacy of treatment are detailed. RESULTS: There were 24 serum or CSF NMDAR-antibody-positive cases and three equivocal serum results. High rates of prodromal cognitive deficits, catatonia, speech disturbance, and antipsychotic sensitivity were observed in the 16 CSF NMDAR-antibody-positive case patients and two CSF NMDAR-antibody-negative case patients, all evident before neurological deterioration with seizures, movement disorder, and autonomic disturbance occurring in the weeks following admission. The majority of these patients (N=17) were treated successfully with immunomodulatory therapy. The nine remaining patients, who were CSF NMDAR antibody negative or equivocal, did not demonstrate any of these features and improved with psychiatric care alone. CONCLUSIONS: These findings suggest that traditional psychiatric care may be appropriate for patients with isolated psychiatric symptoms who have positive serum NMDAR testing when CSF is negative and there are no key clinical features such as cognitive deficits, catatonia, speech disturbance, and antipsychotic sensitivity. However, if these key features are present, a trial of immunomodulatory treatment should be considered with repeated examination of CSF for neuronal antibodies.


Asunto(s)
Encefalitis Antirreceptor N-Metil-D-Aspartato , Autoanticuerpos/sangre , Autoanticuerpos/líquido cefalorraquídeo , Catatonia , Disfunción Cognitiva , Factores Inmunológicos/uso terapéutico , Trastornos Mentales , Receptores de N-Metil-D-Aspartato/inmunología , Trastornos del Habla , Adulto , Encefalitis Antirreceptor N-Metil-D-Aspartato/sangre , Encefalitis Antirreceptor N-Metil-D-Aspartato/líquido cefalorraquídeo , Encefalitis Antirreceptor N-Metil-D-Aspartato/tratamiento farmacológico , Encefalitis Antirreceptor N-Metil-D-Aspartato/inmunología , Catatonia/sangre , Catatonia/líquido cefalorraquídeo , Catatonia/tratamiento farmacológico , Catatonia/inmunología , Disfunción Cognitiva/sangre , Disfunción Cognitiva/líquido cefalorraquídeo , Disfunción Cognitiva/tratamiento farmacológico , Disfunción Cognitiva/inmunología , Femenino , Células HEK293 , Humanos , Masculino , Trastornos Mentales/sangre , Trastornos Mentales/líquido cefalorraquídeo , Trastornos Mentales/tratamiento farmacológico , Trastornos Mentales/inmunología , Persona de Mediana Edad , Queensland , Estudios Retrospectivos , Trastornos del Habla/sangre , Trastornos del Habla/líquido cefalorraquídeo , Trastornos del Habla/tratamiento farmacológico , Trastornos del Habla/inmunología , Adulto Joven
2.
Allergol. immunopatol ; 35(6): 278-279, nov. 2007.
Artículo en En | IBECS | ID: ibc-058254

RESUMEN

Angiotensin-converting enzyme (ACE) inhibitors are the most common medications responsible for angioedema. Angioedema is a potentially life threatening conditions especially in geriatric age patients that they have take a several medications include ACE inhibitors and non steroidal anti inflammatory drugs. We present a case an ACE inhibitor induced angioedema that confused many clinical events


Los inhibidores de la enzima conversora de angiotensina (ACE) son los medicamentos más comunes responsables del angioedema. El angioedema es una amenaza potencial de las condiciones de vida, especialmente en pacientes de edad geriátrica que tienen que tomar varios medicamentos incluidos los inhibidores ACE y antiinflamatorios no esteroides. Se presenta un caso de angioedema inducido por un inhibidor ACE que causó muchas confusiones clínicas


Asunto(s)
Femenino , Persona de Mediana Edad , Humanos , Inhibidores de la Enzima Convertidora de Angiotensina/efectos adversos , Inhibidores de la Enzima Convertidora de Angiotensina/análisis , Angioedema/complicaciones , Pánico , Trastorno de Pánico/inmunología , Trastornos de la Articulación/complicaciones , Trastornos del Habla/complicaciones , Trastornos del Habla/diagnóstico , Corticoesteroides/uso terapéutico , Cetirizina/uso terapéutico , Angioedema/inmunología , Pánico/fisiología , Angioedema/diagnóstico , Trastornos del Habla/inmunología , Angioedema/fisiopatología , Trastornos del Habla/fisiopatología , Trastornos del Habla/terapia , Cilazapril/uso terapéutico , Antihipertensivos/uso terapéutico
3.
Dev Neuropsychol ; 22(1): 351-72, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12405509

RESUMEN

Studies have shown that individuals with language disorders, such as developmental dyslexia and specific language impairment, exhibit impairments in the processing of brief, successive, or rapidly changing auditory information. It is also the case that a higher rate of autoimmune disorders have been identified in those with language-based learning disorders and, conversely, that individuals with autoimmune disorders show a higher incidence of language-related disorders. The rapid auditory processing (RAP) deficits described for older individuals with language impairments may also be used as a behavioral marker to identify infants at higher risk for language delays. Thus, we were interested in examining RAP abilities in a subset of infants with a positive family history of autoimmune disorders. Eleven infants from our ongoing prospective longitudinal studies were identified based on parental response to a question about the presence of a family history of autoimmune disease and compared to 11 matched controls. The RAP threshold of each infant was assessed at 6 and 9 months of age using a conditioned head-turn procedure (using tone pairs with brief interstimulus intervals) and an auditory-visual habituation-recognition memory task using computer-generated consonant-vowel syllables (/ba/ vs. /da/). A visual habituation-recognition memory task that did not require processing of brief temporal cues was also administered. Group differences emerged on the infant RAP tasks, and on language outcome measures at 12 and 16 months of age. Infants from families with a history of autoimmune disorder had significantly higher (i.e., poorer) RAP thresholds and lower language scores than did control infants, whereas visual discrimination scores did not differ between family history infants and controls. Moreover, when brief auditory cues were necessary for the discrimination of /ba/ vs. /da/, infants with a family history of autoimmune disorder performed significantly more poorly than did controls. These findings lend support to the hypothesis that a similar mechanism, perhaps a neural-immune interaction, may underlie the observed co-occurrence of autoimmune disorders and learning impairments.


Asunto(s)
Percepción Auditiva , Enfermedades Autoinmunes/complicaciones , Señales (Psicología) , Trastornos del Lenguaje/inmunología , Trastornos del Lenguaje/psicología , Trastornos del Habla/psicología , Estimulación Acústica , Estudios de Casos y Controles , Cognición , Dislexia/inmunología , Dislexia/psicología , Femenino , Habituación Psicofisiológica , Humanos , Lactante , Masculino , Estudios Prospectivos , Trastornos del Habla/inmunología , Percepción del Habla , Percepción Visual
4.
Brain Dev ; 23 Suppl 1: S108-12, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11738854

RESUMEN

Rett syndrome (RTT) is neurodevelopmental disorder with the onset at critical period of postnatal ontogenesis and age dependent occurrence of clinical manifestations. The aim of the present study was to investigate possible correlations of the age of disease onset with clinical manifestations at the stage 3 of illness and neurobiological parameters. The study was carried out in 38 girls with classical RTT, aged from 3 to 7 years, and twenty and eighteen patients with the disease onset before and after the age of one year were divided into the groups 1 and 2 (Gr1 and Gr2), respectively. Quantitative EEG (QEEG) and measurement of the serum levels of autoantibodies (AAB) to nerve growth factor (NGF) were performed. Clinically, speech and motor functions were significantly more severely affected in the Gr1 than in the Gr2. In QEEG, spectral density of theta activity was significantly higher in Gr1 than in the Gr2. The titer of AAB to NGF was significantly increased in comparison with healthy controls, and the titer in Gr2 was higher than in Gr1. The data obtained suggests that patients with the classical RTT can be divided into subgroups according to the age of disease onset and genetic factors such as mosaicism of MeCP2 mutation may be associated with the heterogeneity of phenotype in RTT patients.


Asunto(s)
Encéfalo/inmunología , Encéfalo/fisiopatología , Síndrome de Rett/inmunología , Síndrome de Rett/fisiopatología , Edad de Inicio , Apraxias/etiología , Apraxias/inmunología , Apraxias/fisiopatología , Encéfalo/crecimiento & desarrollo , Niño , Preescolar , Electroencefalografía , Femenino , Trastornos Neurológicos de la Marcha/etiología , Trastornos Neurológicos de la Marcha/inmunología , Trastornos Neurológicos de la Marcha/fisiopatología , Humanos , Factor de Crecimiento Nervioso/inmunología , Factor de Crecimiento Nervioso/metabolismo , Trastornos del Habla/etiología , Trastornos del Habla/inmunología , Trastornos del Habla/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...